<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nid</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология и диализ</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology and Dialysis</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1680-4422</issn><issn pub-type="epub">2618-9801</issn><publisher><publisher-name>Российское диализное общество</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">nid-530</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ВСЕМИРНЫЙ ДЕНЬ ПОЧКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>WORLD KIDNEY DAY</subject></subj-group></article-categories><title-group><article-title>Хроническая болезнь почек и старение популяции</article-title><trans-title-group xml:lang="en"><trans-title>Chronic kidney disease and the aging population</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Марчелло</surname><given-names>Тонелли</given-names></name><name name-style="western" xml:lang="en"><surname>Marcello</surname><given-names>Tonelli</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мигель</surname><given-names>Риелла</given-names></name><name name-style="western" xml:lang="en"><surname>Miguel</surname><given-names>Riella</given-names></name></name-alternatives><email xlink:type="simple">noemail@neicon.ru</email><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Университет Альберты, Альберта, Канада</institution><country>Россия</country></aff><aff xml:lang="en"><institution>University of Alberta, Alberta, Canada</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Католический университет Параны, Куритиба, Бразилия</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Catholic University of Parana, Curitiba, Brazil</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>13</day><month>09</month><year>2024</year></pub-date><volume>16</volume><issue>1</issue><fpage>6</fpage><lpage>10</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Марчелло Т., Мигель Р., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Марчелло Т., Мигель Р.</copyright-holder><copyright-holder xml:lang="en">Marcello T., Miguel R.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephro.ru/jour/article/view/530">https://journal.nephro.ru/jour/article/view/530</self-uri><abstract><p>Молодости прощается все, хотя она ничего себе не прощает; а старости, которая все себе прощает, ничего не прощается. Джордж Бернард Шоу Во всем мире постоянно увеличивается количество пожилых людей, и наиболее отчетливо эта тенденция заявляет о себе в странах с низкими и умеренными доходами [<xref ref-type="bibr" rid="cit1">1</xref>]. Эти демографические изменения сами по себе можно только приветствовать, так как они являются прямым следствием социально-экономического развития и увеличения средней продолжительности жизни. Но в то же время старение населения оказывает влияние на различные сферы жизни общества, включая государственную политику в целом, а также развитие системы здравоохранения, рынка труда и т. д. [<xref ref-type="bibr" rid="cit2">2</xref>]. Для того чтобы справиться с проблемой старения населения, необходимо активизировать существующие возможности и учитывать все важнейшие составляющие этого неоднозначного процесса. Хроническая болезнь почек (ХБП) является важной проблемой общественного здравоохранения, поскольку с ней связаны негативные последствия для здоровья и чрезвычайно высокие затраты на оказание медицинской помощи. ХБП представляет собой значимый фактор, многократно увеличивающий риск неблагоприятных исходов у пациентов с сахарным диабетом, гипертонией, болезнями сердца и инсультом, каждый из которых, в свою очередь, является основной причиной смерти и инвалидизации пожилых людей [<xref ref-type="bibr" rid="cit3">3</xref>]. Поскольку распространенность ХБП у пожилых высока, влияние старения населения на общественное здоровье отчасти будет зависеть от реакции нефрологического сообщества. 13 марта 2014 года во всем мире будут отмечать 9-й Всемирный День почки (ВДП) - ежегодное событие, являющееся совместной инициативой Международного общества нефрологов и Международной федерации почечных фондов. Начиная с 2006 г., когда ВДП был проведен впервые, он стал наиболее успешной инициативой, повышающей осведомленность о важности заболеваний почек среди законодателей и общества в целом. Темой ВДП 2014 г. стала ХБП у пожилых. В этой статье рассматриваются ключевые связи между функцией почек, возрастом, здоровьем и болезнью, а также обсуждается влияние старения популяции на организацию медицинской помощи больным ХБП. Перевод Д.Ю. Щекочихина и Н.Л. Козловской под редакцией Е.В. Захаровой. Перевод сделан по поручению и одобрен организационным комитетом Всемирного Дня почки.</p></abstract><trans-abstract xml:lang="en"><p>Youth, which is forgiven everything, forgives itself nothing: age, which forgives itself everything, is forgiven nothing. George Bernard Shaw The proportion of older people in the general population is steadily increasing worldwide, with the most rapid growth in low- and middle-income countries [<xref ref-type="bibr" rid="cit1">1</xref>]. This demographic change is to be celebrated, because it is the consequence of socioeconomic development and better life expectancy. However, population aging also has important implications for society - in diverse areas including health systems, labor markets, public policy, social programs, and family dynamics [<xref ref-type="bibr" rid="cit2">2</xref>]. A successful response to the aging population will require capitalizing on the opportunities that this transition offers, as well as effectively addressing its challenges. Chronic kidney disease (CKD) is an important public health problem that is characterized by poor health outcomes and very high health care costs. CKD is a major risk multiplier in patients with diabetes, hypertension, heart disease and stroke - all of which are key causes of death and disability in older people [<xref ref-type="bibr" rid="cit3">3</xref>]. Since the prevalence of CKD is higher in older people, the health impact of population aging will depend in part on how the kidney community responds. March 13, 2014 will mark the celebration of the 9th World Kidney Day (WKD), an annual event jointly sponsored by the International Society of Nephrology and the International Federation of Kidney Foundations. Since its inception in 2006, WKD has become the most successful effort to raise awareness among policymakers and the general public about the importance of kidney disease. The topic for WKD 2014 is «CKD in older people». This article reviews the key links between kidney function, age, health and illness - and discusses the implications of the aging population for the care of people with CKD.</p></trans-abstract></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">World Health Organization. Good health adds life to years: Global brief for World Health Day 2012. Geneva, 2012.</mixed-citation><mixed-citation xml:lang="en">World Health Organization. Good health adds life to years: Global brief for World Health Day 2012. Geneva, 2012.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Wiener J.M., Tilly J. Population ageing in the United States of America: implications for public programmes // Int. J. Epidemiol. 2002. 31. P. 776-781.</mixed-citation><mixed-citation xml:lang="en">Wiener J.M., Tilly J. Population ageing in the United States of America: implications for public programmes // Int. J. Epidemiol. 2002. 31. P. 776-781.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Couser W.G., Remuzzi G., Mendis S. et al. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases // Kidney Int. 2011. 80. P. 1258-1270.</mixed-citation><mixed-citation xml:lang="en">Couser W.G., Remuzzi G., Mendis S. et al. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases // Kidney Int. 2011. 80. P. 1258-1270.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Select Committee on Public Service and Demographic Change. Ready for Aging? Report. House of Lords: London, 2013.</mixed-citation><mixed-citation xml:lang="en">Select Committee on Public Service and Demographic Change. Ready for Aging? Report. House of Lords: London, 2013.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Davies D.F., Shock N.W. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males // J. Clin. Invest. 1950. 29. P. 496-507.</mixed-citation><mixed-citation xml:lang="en">Davies D.F., Shock N.W. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males // J. Clin. Invest. 1950. 29. P. 496-507.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang L., Wang F., Wang L. et al. Prevalence of chronic kidney disease in China: a cross-sectional survey // Lancet. 2012. 379. P. 815-822.</mixed-citation><mixed-citation xml:lang="en">Zhang L., Wang F., Wang L. et al. Prevalence of chronic kidney disease in China: a cross-sectional survey // Lancet. 2012. 379. P. 815-822.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Coresh J., Selvin E., Stevens L.A. et al. Prevalence of chronic kidney disease in the United States // JAMA. 2007. 298. P. 2038-2047.</mixed-citation><mixed-citation xml:lang="en">Coresh J., Selvin E., Stevens L.A. et al. Prevalence of chronic kidney disease in the United States // JAMA. 2007. 298. P. 2038-2047.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang Q.L., Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review // BMC Public. Health. 2008. 8. P. 117.</mixed-citation><mixed-citation xml:lang="en">Zhang Q.L., Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review // BMC Public. Health. 2008. 8. P. 117.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Arora P., Vasa P., Brenner D. et al. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey // CMAJ. 2013. 185. P. E417-423.</mixed-citation><mixed-citation xml:lang="en">Arora P., Vasa P., Brenner D. et al. Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey // CMAJ. 2013. 185. P. E417-423.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">James M.T., Hemmelgarn B.R., Tonelli M. Early recognition and prevention of chronic kidney disease // Lancet. 2010. 375. P. 1296-1309.</mixed-citation><mixed-citation xml:lang="en">James M.T., Hemmelgarn B.R., Tonelli M. Early recognition and prevention of chronic kidney disease // Lancet. 2010. 375. P. 1296-1309.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Kurella M., Covinsky K.E., Collins A.J. et al. Octogenarians and nonagenarians starting dialysis in the United States // Ann. Intern. Med. 2007. 146. P. 177-183.</mixed-citation><mixed-citation xml:lang="en">Kurella M., Covinsky K.E., Collins A.J. et al. Octogenarians and nonagenarians starting dialysis in the United States // Ann. Intern. Med. 2007. 146. P. 177-183.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hemmelgarn B.R., James M.T., Manns B.J. et al. Rates of treated and untreated kidney failure in older vs younger adults // JAMA. 2012. 307. P. 2507-2515.</mixed-citation><mixed-citation xml:lang="en">Hemmelgarn B.R., James M.T., Manns B.J. et al. Rates of treated and untreated kidney failure in older vs younger adults // JAMA. 2012. 307. P. 2507-2515.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Keith D.S., Nichols G.A., Gullion C.M. et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization // Arch. Intern. Med. 2004. 164. P. 659-663.</mixed-citation><mixed-citation xml:lang="en">Keith D.S., Nichols G.A., Gullion C.M. et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization // Arch. Intern. Med. 2004. 164. P. 659-663.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Hemmelgarn B.R., Manns B.J., Lloyd A. et al. Relation between kidney function, proteinuria, and adverse outcomes // JAMA. 2010. 303. P. 423-429.</mixed-citation><mixed-citation xml:lang="en">Hemmelgarn B.R., Manns B.J., Lloyd A. et al. Relation between kidney function, proteinuria, and adverse outcomes // JAMA. 2010. 303. P. 423-429.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">O’Hare A.M., Bertenthal D., Covinsky K.E. et al. Mortality risk stratification in chronic kidney disease: one size for all ages? // J. Am. Soc. Nephrol. 2006. 17. P. 846-853.</mixed-citation><mixed-citation xml:lang="en">O’Hare A.M., Bertenthal D., Covinsky K.E. et al. Mortality risk stratification in chronic kidney disease: one size for all ages? // J. Am. Soc. Nephrol. 2006. 17. P. 846-853.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Stevens P.E., Levin A. Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group M. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline // Ann. Intern. Med. 2013. 158. P. 825-830.</mixed-citation><mixed-citation xml:lang="en">Stevens P.E., Levin A. Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group M. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline // Ann. Intern. Med. 2013. 158. P. 825-830.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Thorsteinsdottir B., Montori V.M., Prokop L.J. et al. Ageism vs. the technical imperative, applying the GRADE framework to the evidence on hemodialysis in very elderly patients // Clin. Interv. Aging. 2013. 8. P. 797-807.</mixed-citation><mixed-citation xml:lang="en">Thorsteinsdottir B., Montori V.M., Prokop L.J. et al. Ageism vs. the technical imperative, applying the GRADE framework to the evidence on hemodialysis in very elderly patients // Clin. Interv. Aging. 2013. 8. P. 797-807.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Chandna S.M., Da Silva-Gane M., Marshall C. et al. Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy // Nephrol. Dial. Transplant. 2011. 26. P. 1608-1614.</mixed-citation><mixed-citation xml:lang="en">Chandna S.M., Da Silva-Gane M., Marshall C. et al. Survival of elderly patients with stage 5 CKD: comparison of conservative management and renal replacement therapy // Nephrol. Dial. Transplant. 2011. 26. P. 1608-1614.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Murtagh F.E., Marsh J.E., Donohoe P. et al. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5 // Nephrol. Dial. Transplant. 2007. 22. P. 1955-1962.</mixed-citation><mixed-citation xml:lang="en">Murtagh F.E., Marsh J.E., Donohoe P. et al. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5 // Nephrol. Dial. Transplant. 2007. 22. P. 1955-1962.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Kurella Tamura M., Covinsky K.E., Chertow G.M. et al. Functional status of elderly adults before and after initiation of dialysis // N. Engl. J. Med. 2009. 361. P. 1539-1547.</mixed-citation><mixed-citation xml:lang="en">Kurella Tamura M., Covinsky K.E., Chertow G.M. et al. Functional status of elderly adults before and after initiation of dialysis // N. Engl. J. Med. 2009. 361. P. 1539-1547.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Lamping D.L., Constantinovici N., Roderick P. et al. Clinical outcomes, quality of life, and costs in the North Thames Dialysis Study of elderly people on dialysis: a prospective cohort study // Lancet. 2000. 356. P. 1543-1550.</mixed-citation><mixed-citation xml:lang="en">Lamping D.L., Constantinovici N., Roderick P. et al. Clinical outcomes, quality of life, and costs in the North Thames Dialysis Study of elderly people on dialysis: a prospective cohort study // Lancet. 2000. 356. P. 1543-1550.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Unruh M.L., Newman A.B., Larive B. et al. The influence of age on changes in health-related quality of life over three years in a cohort undergoing hemodialysis // J. Am. Geriatr. Soc. 2008. 56. P. 1608-1617.</mixed-citation><mixed-citation xml:lang="en">Unruh M.L., Newman A.B., Larive B. et al. The influence of age on changes in health-related quality of life over three years in a cohort undergoing hemodialysis // J. Am. Geriatr. Soc. 2008. 56. P. 1608-1617.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Knoll G.A. Kidney transplantation in the older adult // Am. J. Kidney Dis. 2013. 61. P. 790-797.</mixed-citation><mixed-citation xml:lang="en">Knoll G.A. Kidney transplantation in the older adult // Am. J. Kidney Dis. 2013. 61. P. 790-797.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Merion R.M., Ashby V.B., Wolfe R.A. et al. Deceased-donor characteristics and the survival benefit of kidney transplantation // JAMA. 2005. 294. P. 2726-2733.</mixed-citation><mixed-citation xml:lang="en">Merion R.M., Ashby V.B., Wolfe R.A. et al. Deceased-donor characteristics and the survival benefit of kidney transplantation // JAMA. 2005. 294. P. 2726-2733.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Cohen B., Smits J.M., Haase B. et al. Expanding the donor pool to increase renal transplantation // Nephrol. Dial. Transplant. 2005. 20. P. 34-41.</mixed-citation><mixed-citation xml:lang="en">Cohen B., Smits J.M., Haase B. et al. Expanding the donor pool to increase renal transplantation // Nephrol. Dial. Transplant. 2005. 20. P. 34-41.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Gill J., Bunnapradist S., Danovitch G.M. et al. Outcomes of kidney transplantation from older living donors to older recipients // Am. J. Kidney Dis. 2008. 52. P. 541-552.</mixed-citation><mixed-citation xml:lang="en">Gill J., Bunnapradist S., Danovitch G.M. et al. Outcomes of kidney transplantation from older living donors to older recipients // Am. J. Kidney Dis. 2008. 52. P. 541-552.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Gill J.S., Tonelli M., Johnson N. et al. The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation // Kidney Int. 2005. 68. P. 2345-2351.</mixed-citation><mixed-citation xml:lang="en">Gill J.S., Tonelli M., Johnson N. et al. The impact of waiting time and comorbid conditions on the survival benefit of kidney transplantation // Kidney Int. 2005. 68. P. 2345-2351.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">O’Hare A.M., Kaufman J.S., Covinsky K.E. et al. Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults? // Ann. Intern. Med. 2009. 150. P. 717-724.</mixed-citation><mixed-citation xml:lang="en">O’Hare A.M., Kaufman J.S., Covinsky K.E. et al. Current guidelines for using angiotensin-converting enzyme inhibitors and angiotensin II-receptor antagonists in chronic kidney disease: is the evidence base relevant to older adults? // Ann. Intern. Med. 2009. 150. P. 717-724.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Mohanlal V., Weir M. Kidney Transplantation in the Elderly: It’s Not All Gloom and Doom // ASN Kidney News. 2011. 3. P. 15-17.</mixed-citation><mixed-citation xml:lang="en">Mohanlal V., Weir M. Kidney Transplantation in the Elderly: It’s Not All Gloom and Doom // ASN Kidney News. 2011. 3. P. 15-17.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
